The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bexion
Leadership - Bexion (Inst)
Stock and Other Ownership Interests - Bexion (Inst)
Research Funding - Bexion (Inst)
Travel, Accommodations, Expenses - Bexion (Inst)
BXQ-350, a novel sphingolipid metabolism modulator, in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal cancer (mCRC) patients: A phase 1b/2 randomized study.
 
Daniel Flora
No Relationships to Disclose
 
Reema Patel
No Relationships to Disclose
 
Fa-Chyi Lee
No Relationships to Disclose
 
Gilles Tapolsky
Employment - Bexion
Stock and Other Ownership Interests - Bexion (Inst)
Research Funding - Bexion (Inst)
Patents, Royalties, Other Intellectual Property - Bexion (Inst)
Travel, Accommodations, Expenses - Bexion (Inst)
 
Ray Takigiku
Employment - Bexion
Leadership - Bexion (Inst)
Stock and Other Ownership Interests - Bexion (Inst)
Consulting or Advisory Role - Bexion (Inst)
Research Funding - Bexion (Inst)
Travel, Accommodations, Expenses - Bexion (Inst)
 
Jim Beach
Employment - Bexion
Leadership - Bexion (Inst)
Stock and Other Ownership Interests - Bexion (Inst)
Research Funding - Bexion (Inst)
Travel, Accommodations, Expenses - Bexion (Inst)
 
Michael Gazda
No Relationships to Disclose
 
Tariq Arshad
Employment - Bexion
Leadership - Bexion (Inst)
Stock and Other Ownership Interests - Bexion (Inst)
Research Funding - Bexion (Inst)
Travel, Accommodations, Expenses - Bexion (Inst)